TNGX compared with SYRE: revenue, margins and what each company keeps, and the suppliers and customers both name

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

SYRESpyre Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

TNGXTango Therapeutics, Inc.

SYRESpyre Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SYRE: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TNGX 1

—WuXi AppTecunlistedsupplier

Shared 0

No shared counterparties.

Only SYRE 5

—WuXi Biologics (Hong Kong)unlistedsupplier

—Paragonunlistedsupplier

—WuXi Biologicsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Equiniti Trust Company LLC (f/k/a American Stock Transfer & Trust Company LLC)

unlistedsupplier

1 more · SYRE chain ›

Price

rebased to 0%

TNGX, solidSYRE, dashed

TNGXTango Therapeutics, Inc.

22.72▲+0.84%· post 22.72

Mkt cap$3.8BRevenue$54MQ3 FY25Revenue$42MFY24

SYRESpyre Therapeutics, Inc.

96.44▼−2.55%

ClosedOct 30 '26

Mkt cap$8.5BRevenue—Revenue—

Compare

ClosedOct 30 '26

TNGXTango Therapeutics, Inc.

SYRESpyre Therapeutics, Inc.

22.72▲+0.84%post 22.72

Price

96.44▼−2.55%

$3.8B

Mkt cap

$8.5B

Q3 FY25$54M

Revenue

—

FY24$42M

Revenue

—

TNGX22.72▲+0.84%vsSYRE96.44▼−2.55%ClosedOct 30 '26